BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Carb-X - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Carb-X
X-ORIGINAL-URL:https://carb-x.org
X-WR-CALDESC:Events for Carb-X
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20181028T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Madrid
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20180311T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20181104T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Berlin
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Helsinki
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20181028T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20201025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Ljubljana
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191003T110000
DTEND;TZID=America/New_York:20191003T123000
DTSTAMP:20260403T225217
CREATED:20190729T133232Z
LAST-MODIFIED:20190729T133501Z
UID:3229-1570100400-1570105800@carb-x.org
SUMMARY:Live Webinar: GARDP/REVIVE – Natural products antibiotics: from traditional screening to novel discovery approaches
DESCRIPTION:In this webinar\, Olga Genilloud will discuss the role of natural products in current antibiotic discovery. Topics discussed will include: \n\nScreening strategies to identify novel antibiotics\nCurrent challenges and novel analytical tools\nNew omic approaches supporting antibiotic discovery\n\nThe presentation will be followed by a Q&A session. \n  \nSpeaker: \nOlga Genilloud\, Scientific Director\, Fundación MEDINA\, Granada\, Spain \nModerator: \nLaura Piddock\, Director of Scientific Affairs\, GARDP \nRegister here for this live webinar.
URL:https://carb-x.org/event/live-webinar-gardp-revive-natural-products-antibiotics-from-traditional-screening-to-novel-discovery-approaches/
LOCATION:Webinar\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191002
DTEND;VALUE=DATE:20191007
DTSTAMP:20260403T225217
CREATED:20190201T201142Z
LAST-MODIFIED:20190528T161659Z
UID:2290-1569974400-1570406399@carb-x.org
SUMMARY:IDWeek 2019 Annual Conference
DESCRIPTION:Attendees include Richard Alm\, CARB-X Alliance Director. \nIDWeek is the joint annual meeting of the Infectious Diseases Society of America (IDSA)\, Society for Healthcare Epidemiology of America (SHEA)\, the HIV Medical Association (HIVMA)\, and the Pediatric Infectious Diseases Society (PIDS). \nAt IDWeek\, you will see familiar colleagues and new faces. IDWeek is a forum for health professionals of varied backgrounds to collaborate\, cooperate\, and learn from each other’s expertise. With so many common issues and challenges cutting across our four disciplines\, IDWeek provides an opportunity to learn from each other’s knowledge\, experience and expertise\, for the improvement of patient care and public health. \nThis is an inclusive meeting that offers access to internationally recognized leaders in the field and the opportunity to network with the most highly respected health professionals in infectious diseases\, including HIV. \nTo learn more\, click here. \nTo view the program\, click here. \nTo register for the conference\, click here.
URL:https://carb-x.org/event/idsas-annual-idweek-meeting/
LOCATION:Walter E. Washington Convention Center\, 801 Mount Vernon Pl. NW\,\, Washington D.C.\, DC\, 20001\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190923T180000
DTEND;TZID=America/New_York:20190923T210000
DTSTAMP:20260403T225217
CREATED:20190813T163022Z
LAST-MODIFIED:20190813T163022Z
UID:3280-1569261600-1569272400@carb-x.org
SUMMARY:AMR Challenge: A Night Celebrating Global AMR Fighters
DESCRIPTION:Join HHS Secretary\, Alex Azar\, experts from the U.S. Centers for Disease Control and Prevention\, and hundreds of organizational and global leaders for an evening celebrating the culmination of the AMR Challenge at an unofficial side event of the 74th United Nations General Assembly in New York City.
URL:https://carb-x.org/event/amr-challenge-a-night-celebrating-global-amr-fighters/
LOCATION:Cipriani Midtown\, 110 E. 42nd Street\, New York City\, NY\, 10017\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190910T110000
DTEND;TZID=America/New_York:20190910T123000
DTSTAMP:20260403T225217
CREATED:20190729T132915Z
LAST-MODIFIED:20190729T133433Z
UID:3226-1568113200-1568118600@carb-x.org
SUMMARY:Live Webinar: GARDP/REVIVE – Models for antimicrobial R&D: Advanced and complex in vivo models for infectious disease research
DESCRIPTION:In this webinar\, Peter Warn will review the experimental design and conduct of advanced or complex animal models for antimicrobial research. \nThis webinar is designed as a follow on from the webinar of William J. Weiss: Models for antimicrobial R&D: Development and use of in vivo models for infectious disease research (see here: http://bit.ly/2ZiPt6y). \nTopics covered in this webinar will include: \n\nIn depth review of animal models of pneumonia\, UTI and tissue infections including biofilm models.\nAnimal models of non-traditional drugs where CFU might not be a suitable biomarker.\nTips\, hints and pitfalls when trying to generate informative data in PKPD studies.\n\nThe presentation will be followed by a Q&A session. \n  \nSpeaker: \nPeter Warn\, Senior Vice President\, Anti-infective Discovery\, Evotec \nModerator: \nWilliam J. Weiss\, Director\, PreClinical Services\, University of North Texas System College of Pharmacy \nRegister here for this live webinar.
URL:https://carb-x.org/event/live-webinar-gardp-revive-models-for-antimicrobial-rd-advanced-and-complex-in-vivo-models-for-infectious-disease-research/
LOCATION:Webinar\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190910
DTEND;VALUE=DATE:20190911
DTSTAMP:20260403T225217
CREATED:20190201T204201Z
LAST-MODIFIED:20190201T204201Z
UID:2297-1568073600-1568159999@carb-x.org
SUMMARY:Institut Pasteur Financing Start-Up Breakfast
DESCRIPTION:Additional Details Forthcoming.
URL:https://carb-x.org/event/institut-pasteur-financing-start-up-breakfast/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190906T120000
DTEND;TZID=America/New_York:20190906T180000
DTSTAMP:20260403T225217
CREATED:20190308T181941Z
LAST-MODIFIED:20190722T171323Z
UID:2494-1567771200-1567792800@carb-x.org
SUMMARY:CARB-X Product Developer Conference
DESCRIPTION:We are excited to announce that CARB-X will be hosting our first ever CARB-X Developer Conference. The conference will be held on September 6th\, 2019 in Boston\, immediately following the conclusion of the ASM-ESCMID conference.  Additional details will follow.  Please save the date!\n\n\nThis  will be an excellent networking event for CARB-X product developers\, who will have the opportunity to connect with and learn from some of the most innovative members of the AMR community\, including companies in our diverse portfolio as well as representatives from our expanded accelerator network. \nIf applicable\, please feel free to use your CARB-X travel budget to fund attendance for up to three members of your team.  Allowable incurred travel costs will be reimbursed after the meeting via the standard CARB-X invoicing process.  Please click here for further travel guidance\, and if you have any additional questions please reach out to your CARB-X Finance and Grants Manager for clarity. \nWe will follow up soon with additional details for the CARB-X Product Developer Conference.  Please forward this save-the-date to those interested on your team\, including principle investigators\, science leads\, and project managers.  Please contact Dhanuraj Shetty at dshetty@bu.edu with any urgent questions or concerns. \nMark your calendars and join us on September 6th\, 2019!
URL:https://carb-x.org/event/carb-x-product-developer-conference/
LOCATION:Boston\, Venue Forthcoming
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20190906T081500
DTEND;TZID=Europe/London:20190906T180000
DTSTAMP:20260403T225217
CREATED:20190605T140043Z
LAST-MODIFIED:20190605T140139Z
UID:3092-1567757700-1567792800@carb-x.org
SUMMARY:CeBIL Annual Symposium 2019: Legal Innovation to Support the Development of Antimicrobial Drugs
DESCRIPTION:This symposium explores the complex interactions between law and antimicrobial research and development. Advancing our understanding of this ecosystem will help design a better legal toolkit to promote antimicrobial innovation and limit the impact of resistance on global health. \nHeld at the University of Cambridge\, an international hub for legal and scientific expertise\, we hope the event will mobilize legal\, economic\, business\, medical and scientific experts – early\, mid\, and late career – who recognize the need to work together to avert the AMR crisis. \nClick here to learn more. \nClick here to register.
URL:https://carb-x.org/event/cebil-annual-symposium-2019-legal-innovation-to-support-the-development-of-antimicrobial-drugs/
LOCATION:Christ’s College Cambridge\, St. Andrew's Street\, Cambridge\, CB2 3BU\, United Kingdom
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190906
DTEND;VALUE=DATE:20190909
DTSTAMP:20260403T225217
CREATED:20190201T200954Z
LAST-MODIFIED:20190201T200959Z
UID:2286-1567728000-1567987199@carb-x.org
SUMMARY:5th ESCMID Conference on Vaccines
DESCRIPTION:Online registration will open in spring 2019 – Check back soon for details.
URL:https://carb-x.org/event/5th-escmid-conference-on-vaccines/
LOCATION:Bilbao – Spain\, Bilbao\, Spain
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190904T183000
DTEND;TZID=America/New_York:20190904T210000
DTSTAMP:20260403T225217
CREATED:20190815T140954Z
LAST-MODIFIED:20190815T140954Z
UID:3301-1567621800-1567630800@carb-x.org
SUMMARY:Harvard Museum of Natural History Reception and Mixer
DESCRIPTION:Sponsored by the Harvard Microbial Sciences Initiative and the Boston Area Antimicrobial Research Network \n\n\n\n\nDrinks\, hors d’oeuvres\, and exclusive private access to the Harvard Museum of Natural History https://hmnh.harvard.edu/. This is a chance to unwind with fellow attendees at the ASM/ESCMID Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance\, and meet those from the Harvard University Microbial Sciences Initiative and Boston Area Antimicrobial Resistance Network sharing that interest. The museum is the quintessential university natural history museum with many unique and historical collections and displays\, located on the main Cambridge campus of Harvard University. \nSPACE IS LIMITED to the first 150 to RSVP.\nTo reserve your place – reply to: michael_gilmore@meei.harvard.edu. Copy the subject line I WILL ATTEND\, and provide your name\, affiliation and email. You will be provided a map\, directions and an ENTRY TICKET in response.
URL:https://carb-x.org/event/harvard-museum-of-natural-history-reception-and-mixer/
LOCATION:Harvard Campus\, 52 Oxford Street\, Cambridge\, MA\, 02138\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190903
DTEND;VALUE=DATE:20190907
DTSTAMP:20260403T225217
CREATED:20190201T200727Z
LAST-MODIFIED:20190214T192208Z
UID:2283-1567468800-1567814399@carb-x.org
SUMMARY:Annual ASM/ESCMID Conference on Antibiotic Development to Meet the Challenge of AMR
DESCRIPTION:The ASM/ECSMID Conference on Drug Development returns to Boston\, Massachusetts for 2019. Check back soon for program details. \nAntimicrobial drug resistance (AMR) is an urgent global health problem. New antimicrobial drug development is increasingly viewed as a priority by National and International bodies. There are relatively few agents in developmental pipelines and a paucity of identified microbiological targets that can be exploited for drug development. Co-sponsored by the American Society for Microbiology (ASM) and the European Society for Clinical Microbiology and Infectious Diseases (ESCMID)\, this multidisciplinary meeting will address the challenges\, opportunities and current requirements for antimicrobial drug development for AMR.
URL:https://carb-x.org/event/annual-asm-escmid-conference-on-antibiotic-development/
LOCATION:Boston\, Venue Forthcoming\, Boston\, MA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190820T110000
DTEND;TZID=America/New_York:20190820T123000
DTSTAMP:20260403T225217
CREATED:20190723T181013Z
LAST-MODIFIED:20190723T181112Z
UID:3210-1566298800-1566304200@carb-x.org
SUMMARY:Live Webinar: GARDP/REVIVE - Models for antimicrobial R&D: Computational modelling for population PK and PKPD
DESCRIPTION:The overall goal of this series of webinars is to provide\, for the non-clinical developer\, an understanding of the risks of development for various kinds of antibacterial products. \nIn this webinar\, Lena Friberg and Elisabet Nielsen (Department of Pharmaceutical Biosciences\, Uppsala University\, Sweden)\, will discuss: \n\nPopulation PK modelling to characterize drug exposure and variability\nPKPD-modelling to characterize preclinical time-kill data\nPKPD-modelling for translation to patients\nModel-based dose-individualization\n\nThe presentation will be followed by a Q&A session. \n  \nSpeakers: \nLena Friberg and Elisabet Nielsen\, Department of Pharmaceutical Biosciences\, Uppsala University\, Sweden \nModerator: \nUrsula Theuretzbacher\, Center for Anti-Infective Agents\, Vienna\, Austria \nRegister here for this live webinar.
URL:https://carb-x.org/event/live-webinar-gardp-revive-models-for-antimicrobial-rd-computational-modelling-for-population-pk-and-pkpd/
LOCATION:Webinar\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190812T080000
DTEND;TZID=America/New_York:20190813T170000
DTSTAMP:20260403T225217
CREATED:20190206T172158Z
LAST-MODIFIED:20190206T172158Z
UID:2353-1565596800-1565715600@carb-x.org
SUMMARY:UK Medical Research Council National PhD Training Programme in AMR - Annual Conference
DESCRIPTION:Keynote lecture given by Kevin Outterson\, Executive Director of CARB-X. \nAdditional details forthcoming.
URL:https://carb-x.org/event/uk-medical-research-council-national-phd-training-programme-in-amr-annual-conference/
LOCATION:University of Bristol\, Bristol\, BS8 1TD\, United Kingdom
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190724
DTEND;VALUE=DATE:20190726
DTSTAMP:20260403T225217
CREATED:20190611T144303Z
LAST-MODIFIED:20190611T144303Z
UID:3107-1563926400-1564099199@carb-x.org
SUMMARY:The Role of NIH in Drug Development Innovation and its Impact on Patient Access: A workshop
DESCRIPTION:This is an open session hosted by the National Academy of Sciences\, Engineering\, and Medicine.  The 1.5-day public workshop to will be held on July 24-25\, 2019 in Washington\, D.C and focus on the translation of federal investments in biomedical science to innovation in drug development and how the public benefits from that investment in terms of drug pricing and access. The meeting will feature invited presentations and panel discussions on topics that may include: \n  \n\nhow federal funding for biomedical research\, particularly via NIH\, has contributed to new drug development\, both directly and indirectly\nthe pricing of drugs that have benefited from federal investments in biomedical science;\nthe role of technology and patent transfer to and from entrepreneurial organizations associated with NIH-funded research\npotential ways to better track\, quantify\, and document NIH contributions to innovation in drug development\npotential strategies and policies to facilitate the translation of federally-funded biomedical research into innovations in drug development and to help ensure that the public has affordable access to those innovative medicines.\nThe planning committee will develop the agenda\, select and invite subject matter experts and discussants\, and moderate the discussions. A proceedings of the event will be prepared in accordance with institutional guidelines.\n\nTo learn more\, click here.
URL:https://carb-x.org/event/the-role-of-nih-in-drug-development-innovation-and-its-impact-on-patient-access-a-workshop/
LOCATION:The National Academies Keck Building\, 500 5th Street NW\, Washington\, DC\, 20001\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190722T080000
DTEND;TZID=America/New_York:20190722T170000
DTSTAMP:20260403T225217
CREATED:20190610T155029Z
LAST-MODIFIED:20190610T155039Z
UID:3105-1563782400-1563814800@carb-x.org
SUMMARY:Deadline to submit updates to the World Health Organization clinical antibacterial pipeline
DESCRIPTION:Please share any pipeline additions and changes that you are aware of by 22 July 2019. Download and use this form to provide updates. The latest pipeline update (as of July 1\, 2018)\, can be found as a manuscript (Theuretzbacher et al. Lancet ID 2018)\, and as a set of summary tables. Contact Sarah Paulin (paulins@who.int).
URL:https://carb-x.org/event/deadline-to-submit-updates-to-the-world-health-organization-clinical-antibacterial-pipeline/
LOCATION:CARB-X\, 765 Commonwealth Ave\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190709T110000
DTEND;TZID=America/New_York:20190709T123000
DTSTAMP:20260403T225217
CREATED:20190528T160533Z
LAST-MODIFIED:20190620T144353Z
UID:3060-1562670000-1562675400@carb-x.org
SUMMARY:Live Webinar: GARDP/REVIVE Infection models for antimicrobial R&D: Intracellular models
DESCRIPTION:The overall goal of this series of webinars is to provide\, for the non-clinical developer\, an understanding of the risks of development for various kinds of antibacterial products. \nIn this webinar\, Françoise van Bambeke\, Research Director Cellular and Molecular Pharmacology\, Louvain Drug Research Institute\, Catholic University of Louvain (FR)\, will talk about intracellular activity of antibiotics. Topics discussed will include: \n\nThe role of intracellular survival in chronic infections and its contribution to poor response to antibiotics\nIn vitro models to study intracellular activity of antibiotics\nCellular pharmacokinetic (PK) parameters predictive of intracellular potency for antibiotics\nCellular pharmacodynamics (PD) parameters predictive of intracellular efficacy for antibiotics\n\nThe presentation will be followed by a Q&A session \nSpeakers:\nFrançoise van Bambeke\, Research Director Cellular and Molecular Pharmacology\, Louvain Drug Research Institute\, Catholic University of Louvain (FR) \nModerator:\nLaura Piddock\, Director of Scientific Affairs\, GARDP \nRegister here for this live webinar.
URL:https://carb-x.org/event/live-webinar-gardp-revive-infection-models-for-antimicrobial-rd-intracellular-models/
LOCATION:Boston University School of Law\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190705
DTEND;VALUE=DATE:20190706
DTSTAMP:20260403T225217
CREATED:20190201T204108Z
LAST-MODIFIED:20190201T204108Z
UID:2295-1562284800-1562371199@carb-x.org
SUMMARY:Institut Pasteur Financing Start-Ups in Life Sciences Workshop
DESCRIPTION:Additional Details Forthcoming.
URL:https://carb-x.org/event/institut-pasteur-financing-start-ups-in-life-sciences-workshop/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190626T103000
DTEND;TZID=America/New_York:20190626T113000
DTSTAMP:20260403T225217
CREATED:20190620T134850Z
LAST-MODIFIED:20190620T134850Z
UID:3143-1561545000-1561548600@carb-x.org
SUMMARY:Live Webinar: GARDP/REVIVE - Find out how GARDP is redoubling its efforts to accelerate the development and delivery of new and improved antibiotics
DESCRIPTION:In this webinar\, Dr Manica Balasegaram\, GARDP’s Executive Director will highlight GARDP’s role in accelerating the implementation of WHO’s Global Action Plan\, and share GARDP’s updated strategy. Following his presentation\, you will have the opportunity to ask questions in a Q&A session moderated by Jennifer Katz\, GARDP’s Director of External Affairs. \nRegister here for this live webinar.
URL:https://carb-x.org/event/live-webinar-gardp-revive-find-out-how-gardp-is-redoubling-its-efforts-to-accelerate-the-development-and-delivery-of-new-and-improved-antibiotics/
LOCATION:Boston University School of Law\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190625
DTEND;VALUE=DATE:20190629
DTSTAMP:20260403T225217
CREATED:20190206T170153Z
LAST-MODIFIED:20190227T152450Z
UID:2342-1561420800-1561766399@carb-x.org
SUMMARY:International Council of Academies of Engineering and Technological Sciences (CAETS) Conference
DESCRIPTION:Speakers include Kevin Outterson\, Executive Director of CARB-X. \nThe Royal Swedish Academy of Engineering Sciences (IVA) is hosting the yearly conference for the International Council of Academies of Engineering and Technological Sciences (CAETS) in 2019. CAETS in a independent non-political\, non-governmental international organization of engineering and technological science academies worldwide. The conference will focus on what engineering and technological science has accomplished in the last 100 years as well as future challenges\, focusing on the topics of Health\, Energy\, Affordable Living\, Superintelligens and Distrubution of Resources. The conference will focus on how engineering and technological science can morph into the future and contribute to solutions. \n 
URL:https://carb-x.org/event/international-council-of-academies-of-engineering-and-technological-sciences-caets-conference/
LOCATION:Stockholm\, Stockholm\, Sweden
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20190624T071500
DTEND;TZID=America/Los_Angeles:20190624T081500
DTSTAMP:20260403T225217
CREATED:20190207T143629Z
LAST-MODIFIED:20190214T192046Z
UID:2360-1561360500-1561364100@carb-x.org
SUMMARY:ASM Microbe Breakout Session - Enabling Academia to Fill the Discovery Gap
DESCRIPTION:Presentations developed in cooperation with GARDP\, CARB-X\, and REPAIR Impact Fund. \nAntimicrobial resistance (AMR) continues to be a major problem that is not being addressed adequately by the pharmaceutical industry. Academic research is more frequently serving as a source for novel antimicrobial agents to treat infections caused by antibiotic-resistant organisms. In this session\, drug discovery efforts originating from academic laboratories will be discussed. The importance of collaborative efforts will be emphasized.
URL:https://carb-x.org/event/enabling-academia-to-fill-the-discovery-gap-developed-in-cooperation-with-gardp-carb-x-and-repair-impact-fund/
LOCATION:Moscone Center\, 747 Howard Street\, San Francisco\, CA\, 94103\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190620
DTEND;VALUE=DATE:20190625
DTSTAMP:20260403T225217
CREATED:20190201T200421Z
LAST-MODIFIED:20190214T191858Z
UID:2280-1560988800-1561420799@carb-x.org
SUMMARY:ASM Microbe 2019
DESCRIPTION:Each day at ASM Microbe 2019 offers you the chance to delve into your scientific interest and specialties\, discover cutting-edge research in the poster and oral presentations\, and connect with a world of microbiology experts. View the ASM Microbe 2019 Schedule at a Glance for a preliminary peek at what is in store for you.
URL:https://carb-x.org/event/asm-microbe-2019/
LOCATION:Moscone Center\, 747 Howard Street\, San Francisco\, CA\, 94103\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20190611T170000
DTEND;TZID=Europe/Berlin:20190611T183000
DTSTAMP:20260403T225217
CREATED:20190528T160224Z
LAST-MODIFIED:20190528T160702Z
UID:3058-1560272400-1560277800@carb-x.org
SUMMARY:Live Webinar: GARDP/REVIVE Models for antimicrobial R&D: Development and use of in vivo models for infectious disease research
DESCRIPTION:The overall goal of this series of webinars is to provide\, for the non-clinical developer\, an understanding of the risks of development for various kinds of antibacterial products. \nIn this webinar\, William J. Weiss\, Director\, PreClinical Services\, University of North Texas System College of Pharmacy\, will introduce experimental design of animal models for antimicrobial research. He will discuss questions such as 1) Where to start and what model to use? 2) Are animal models of bacterial infection reflective of the clinical condition? 3) Are in vivo animal model results predictive of clinical efficacy? The presentation will be followed by a Q&A session moderated by Peter Warn\, Senior Vice President\, Anti-infective Discovery\, Evotec. \nSpeakers:\nWilliam J. Weiss\, Director\, PreClinical Services\, University of North Texas System College of Pharmacy \nModerator:\nPeter Warn\, Senior Vice President\, Anti-infective Discovery\, Evotec \nRegister here for this live webinar.
URL:https://carb-x.org/event/live-webinar-gardp-revive-models-for-antimicrobial-rd-development-and-use-of-in-vivo-models-for-infectious-disease-research/
LOCATION:Boston University School of Law\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190611T100000
DTEND;TZID=America/New_York:20190611T110000
DTSTAMP:20260403T225217
CREATED:20190517T135538Z
LAST-MODIFIED:20190528T155538Z
UID:3015-1560247200-1560250800@carb-x.org
SUMMARY:Live Webinar: Funding Opportunities for Antimicrobial Drug Development from the Cystic Fibrosis Foundation
DESCRIPTION:Interested in new funding opportunities for infection drug development?\nThe Cystic Fibrosis Foundation (CFF) has teamed up with CARB-X to host a live webinar on June 11\, from 10:00am – 11:00am ET\, to introduce their new Infection Research Initiative. \nDuring the webinar\, Dr. Ann Field\, Senior Director of Drug Discovery and Development at the Cystic Fibrosis Foundation\, will discuss potential funding opportunities for therapeutic development of anti-infectives in key organisms of interest for CF infections.  The presentation will be followed by an interactive Q&A session. \nWebinar Summary\nLearn about funding opportunities for infection drug development through the Cystic Fibrosis Foundation. This webinar will include: \n\nOverview of the CF Foundation and the recently announced Infection Research Initiative\nCF Foundation interest in supporting therapeutic development for anti-infectives in key organisms of interest for CF infections\nTherapeutic Development Award Process and collaboration opportunities\n\nTo join this webinar\, please register here. \nIf you have questions or comments\, please let us know. Feel free to email your questions or comments to Raj Shetty at dshetty@carbx.org before the webinar\, or save them for the live Q&A session following the presentation.  We look forward to hearing from you!
URL:https://carb-x.org/event/webinar-funding-opportunities-for-antimicrobial-drug-development-from-the-cystic-fibrosis-foundation/
LOCATION:Boston University School of Law\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190605
DTEND;VALUE=DATE:20190607
DTSTAMP:20260403T225217
CREATED:20190226T195721Z
LAST-MODIFIED:20190305T211145Z
UID:2461-1559692800-1559865599@carb-x.org
SUMMARY:Medical\, Biomedical & Biodefense: Support to the Warfighter Symposium
DESCRIPTION:Panelists members include Kevin Outterson\, Executive Director of CARB-X\, on the “Public-Private Partnerships: Research and Development Consortia and Accelerators” panel. \n\n\n\nThis panel will discuss the use of public-private partnerships as models for stimulating innovation through sponsored research and development. The panelists will provide overviews of several partnership-enabled consortia and accelerators\, including BARDA’s new Division of Research\, Innovation\, and Ventures and their participation in the partnership\, Combating Antibiotic Resistant Bacteria\, and\, as well as DoD’s Medical CBRN Defense Consortium and Medical Technology Enterprise Consortium. Presenters will discuss their organization’s background and structure\, as well as their unique mechanisms for engaging the research community to solve significant public health and biomedical challenges. \n\n\n\nThe Symposium will focus on two separate tracts. The first\, “Medical Support to the Warfighter\,” will connect businesses and university researchers with military and other federal agencies that require or purchase medical supplies\, equipment\, devices\, pharmaceuticals\, information technology and services\, or fund medical-related research and development. \nThe second tract\, “Biomedical and Biodefense Support to the Warfighter\,” will focus on establishing dialogue between industry and academia-based technology innovators and military and government officials to address the future biomedical and biodefense needs of the military and our nation. \n\nTo learn more\, please click here.
URL:https://carb-x.org/event/medical-biomedical-biodefense-support-to-the-warfighter-symposium/
LOCATION:The Friday Conference Center\, 100 Friday Center Drive\, Chapel Hill\, NC\, 27599\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20190604T133000
DTEND;TZID=Europe/Berlin:20190604T150000
DTSTAMP:20260403T225217
CREATED:20190528T155449Z
LAST-MODIFIED:20190528T160555Z
UID:3052-1559655000-1559660400@carb-x.org
SUMMARY:Live Webinar: GARDP/REVIVE Mining Chemical Libraries for New Antibacterials - Session 2
DESCRIPTION:The overall goal of this series of webinars is to provide\, for the non-clinical developer\, an understanding of the risks of development for various kinds of antibacterial products. \nIn this webinar the recording of Carl Balibar’s presentation ‘Mining of chemical libraries for new antibacterials’ (original webinar on 21 May) will be followed by another live Q&A session with Carl. \nDespite the promise of target-based drug discovery ushered in by the genomics era\, no mechanistically novel rationally designed antibiotic has reached clinically utility to address the threat of multi-drug resistant bacterial pathogens. Phenotypic screening remains the primary source for new antibacterial compounds\, which mainly come from mining various chemical libraries. In this webinar\, Carl Balibar (Merck Research Laboratories) will discuss screen design\, target bias\, and hit-prioritization strategies to identify those entities with the greatest opportunity to be developed into the next new antibiotic. \nSpeakers:\nCarl Balibar\, Principal Scientist\, Merck Research Laboratories \nModerator:\nBenjamin Blasco\, Discovery Senior Project Manager\, GARDP \nRegister here for this live webinar.
URL:https://carb-x.org/event/mining-chemical-libraries-for-new-antibacterials-session-2/
LOCATION:Boston University School of Law\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190603
DTEND;VALUE=DATE:20190607
DTSTAMP:20260403T225217
CREATED:20190201T195534Z
LAST-MODIFIED:20190214T191645Z
UID:2275-1559520000-1559865599@carb-x.org
SUMMARY:2019 BIO International Convention
DESCRIPTION:The BIO International Convention (BIO) attracts 16\,000+ biotechnology and pharma leaders who come together for one week of intensive networking to discover new opportunities and promising partnerships. BIO brings together a wide spectrum of life science and application areas including drug discovery\, biomanufacturing\, genomics\, biofuels\, nanotechnology and cell therapy. \nThe key benefits of attending the 2019 BIO International Convention are access to global biotech and pharma leaders via BIO One-on-One Partnering\, exposure to industry thought-leaders with over 500 education sessions at your fingertips\, and unparalleled networking opportunities with 16\,000+ attendees from 67 countries. \nSee the schedule here.
URL:https://carb-x.org/event/2019-bio-international-convention/
LOCATION:Philadelphia Convention Center\, 1101 Arch Street\, Philadelphia\, PA\, 19107\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190531T100000
DTEND;TZID=America/New_York:20190531T114500
DTSTAMP:20260403T225217
CREATED:20190529T132958Z
LAST-MODIFIED:20190529T132958Z
UID:3069-1559296800-1559303100@carb-x.org
SUMMARY:CARB-X Presentation: 2019 Funding Rounds
DESCRIPTION:Presentation by Karen Gallant\, CARB-X Acting R&D Chief/Deputy Director.  Attendees include Richard Alm\, CARB-X Alliance Director. \nPlease join NCBiotech and RTI International as we host CARB-X Global R&D Project Director Karen Gallant for an informational session about CARB-X and the upcoming funding rounds. Karen will provide an overview of the CARB-X initiative and leave plenty of time to get all questions answered. This event is FREE to attend. \nFor further information\, please refer to the CARB-X press release and website. \n\nAgenda\n10:00 a.m. – Presentation by Karen Gallant\, Global R&D Project Director\, CARB-X\n10:30 a.m. – Presentation: RTI International as a CARB-X Accelerator\n10:45 a.m. – Q&A Session\n11:15 a.m. – Networking\n11:45 a.m. – Adjourn \n\n\nRegistration\nThere is some availability for a few companies to have one-on-one meetings with CARB-X. If you are interested\, please select that option on the registration page.
URL:https://carb-x.org/event/carb-x-presentation-2019-funding-rounds/
LOCATION:North Carolina Biotechnology Center\, 15 T.W. Alexander Drive\, Research Triangle Park\, NC\, 27709-3547\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190528
DTEND;VALUE=DATE:20190529
DTSTAMP:20260403T225217
CREATED:20190305T210241Z
LAST-MODIFIED:20190501T141348Z
UID:2489-1559001600-1559087999@carb-x.org
SUMMARY:Global AMR R&D Hub “Increasing Investments for AMR R&D” Workshop
DESCRIPTION:Participants include Kevin Outterson\, Executive Director of CARB-X. \nThe Global AMR R&D Hub is pleased to announce a one-day workshop on “Increasing Investments\nfor AMR R&D”\, which will take place on Tuesday May 28 2019 in Geneva\, Switzerland. The event\nwill gather representatives from governments\, funders\, industry\, investors and other stakeholders\ninterested in the field of antimicrobial resistance. \nAntimicrobial resistance (AMR) represents an urgent major global health threat. Currently\, there is\nan insufficient number of treatments and tools in the AMR research and development (R&D)\npipeline to tackle this issue. Building on ongoing initiatives\, increasing investments across the One\nHealth spectrum is required. In particular\, more effort is needed in the animal and plant fields as\nwell as applicability in low- and middle-income countries (LMIC). \nThis workshop aims to discuss investments and financing mechanisms for AMR R&D and provide\nrecommendations for funders and investors on how to address the vital issue of increasing\ninvestments in AMR R&D in a One Health context that also considers applicability in LMIC. \nPlease click here to learn more. \n 
URL:https://carb-x.org/event/global-amr-rd-hub-increasing-investments-for-amr-rd-workshop/
LOCATION:Domaine de Penthes\, Chemin de l'Impératrice 18\, Pregny-Chambésy\, 1292\, Switzerland
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20190521T170000
DTEND;TZID=Europe/Helsinki:20190521T183000
DTSTAMP:20260403T225217
CREATED:20190314T170711Z
LAST-MODIFIED:20190404T155846Z
UID:2558-1558458000-1558463400@carb-x.org
SUMMARY:GARDP Mining Chemical Libraries for New Antibacterials
DESCRIPTION:Despite the promise of target-based drug discovery ushered in by the genomics era\, no mechanistically novel rationally designed antibiotic has reached clinically utility to address the threat of multi-drug resistant bacterial pathogens. Phenotypic screening remains the primary source for new antibacterial compounds\, which mainly come from mining various chemical libraries. In this webinar\, Carl Balibar (Merck Research Laboratories) will discuss screen design\, target bias\, and hit-prioritization strategies to identify those entities with the greatest opportunity to be developed into the next new antibiotic. \nThe overall goal of this series of webinars is to provide\, for the non-clinical developer\, an understanding of the risks of development for various kinds of antibacterial products. In this third webinar\, we will discuss the development of antibacterial drug enhancer combinations and non-traditional products. \nPlease note\, this webinar has been rescheduled from April 4th to May 21st\, 2019. \nThe webinar will be held from 5:00 pm – 6:30 pm CEST / 11:00 pm – 12:30 pm EDT. \nThe presentation will be followed by a Q&A session. \nRegister here for this live webinar.
URL:https://carb-x.org/event/mining-chemical-libraries-for-new-antibacterials/
LOCATION:Webinar\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190516T090000
DTEND;TZID=America/New_York:20190516T100000
DTSTAMP:20260403T225217
CREATED:20190509T203055Z
LAST-MODIFIED:20190528T161825Z
UID:2992-1557997200-1558000800@carb-x.org
SUMMARY:Live Webinar: CARB-X 2019 Funding Rounds
DESCRIPTION:Kevin Outterson\, CARB-X Executive Director\, and Karen Gallant\, CARB-X Global R&D Project Director\, present details of CARB-X’s four new funding rounds announced April 30\, 2019\, and answer questions during this webinar. To attend the live webinar\, please register by clicking the link below. A recording of the webinar will be available for viewing shortly after the event. The recording will be available on the CARB-X website in the Apply > What CARB-X funds section. \nPlease click here to register.
URL:https://carb-x.org/event/carb-x-2019-funding-rounds-webinar/
LOCATION:Webinar\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
ORGANIZER;CN="CARB-X":MAILTO:carbx@bu.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190506
DTEND;VALUE=DATE:20190512
DTSTAMP:20260403T225217
CREATED:20190201T195029Z
LAST-MODIFIED:20190214T191346Z
UID:2272-1557100800-1557619199@carb-x.org
SUMMARY:37th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID)
DESCRIPTION:The 37​th Annual Meeting of the European Society for Paediatric Infectious Diseases will feature a wide range of sessions and learning opportunities showcasing the latest research and developments in the field hosted by leading international experts.  The meeting aims to bring together the most prominent researchers in the field of paediatric infectious diseases\, immunology and epidemiology and to fill in the gaps between these disciplines in a relaxed\, smart albeit casual atmosphere.
URL:https://carb-x.org/event/37th-annual-meeting-of-the-european-society-for-paediatric-infectious-diseases-espid/
LOCATION:Ljubljana\, Slovenia
END:VEVENT
END:VCALENDAR